Tongue hyperpigmentation during interferon-alpha and ribavirin therapy

被引：6
|
作者：
Aguayo-Leiva, Ingrid [1 ]
Perez, Bibiana [1 ]
Salguero, Irene [1 ]
Jaen, Pedro [1 ]
机构：
[1] Hosp Ramon & Cajal, Dept Dermatol, E-28034 Madrid, Spain
来源：
EUROPEAN JOURNAL OF DERMATOLOGY | 2009年 / 19卷 / 03期
关键词：
CHRONIC HEPATITIS-C; VIRUS;
D O I：
10.1684/ejd.2009.0665
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：291 / 292
页数：3
相关论文
共 50 条
  • [1] Tongue hyperpigmentation during interferon therapy
    Karabay, Oguz
    Goksugur, Nadir
    Ogutlu, Aziz
    JOURNAL OF DERMATOLOGY, 2011, 38 (03): : 290 - 291
  • [2] Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infection
    Willems, M
    Munte, K
    Vrolijk, JM
    Den Hollander, JC
    Böhm, M
    Kemmeren, MH
    De Man, RA
    Brouwer, JT
    BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 (02) : 390 - 394
  • [3] Takotsubo cardiomyopathy and transient thyrotoxicosis during combination therapy with interferon-alpha and ribavirin for chronic hepatitis C
    Carmen Sorina Martin
    Luminita Nicoleta Ionescu
    Carmen Gabriela Barbu
    Anca Elena Sirbu
    Ioana Maria Lambrescu
    Ioana Smarandita Lacau
    Doina Ruxandra Dimulescu
    Simona Vasilica Fica
    BMC Endocrine Disorders, 14
  • [4] Takotsubo cardiomyopathy and transient thyrotoxicosis during combination therapy with interferon-alpha and ribavirin for chronic hepatitis C
    Martin, Carmen Sorina
    Ionescu, Luminita Nicoleta
    Barbu, Carmen Gabriela
    Sirbu, Anca Elena
    Lambrescu, Ioana Maria
    Lacau, Ioana Smarandita
    Dimulescu, Doina Ruxandra
    Fica, Simona Vasilica
    BMC ENDOCRINE DISORDERS, 2014, 14
  • [5] Retreatment with interferon-alpha and ribavirin in primary interferon-alpha non-responders with chronic hepatitis C
    Teuber, G
    Berg, T
    Hoffmann, RM
    Leifeld, L
    Lafrenz, M
    Spengler, U
    Pape, GR
    Hopf, U
    Zeuzem, S
    DIGESTION, 2000, 61 (02) : 90 - 97
  • [6] Thyroid disorders in patients with chronic hepatitis C using interferon-alpha and ribavirin therapy
    de Oliveira Andrade, Luis Jesuino
    Atta, Ajax Merces
    Brito de Sousa Atta, Maria Luiza
    Kalil Mangabeira, Celia Neder
    Parana, Raymundo
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2011, 15 (04): : 377 - 381
  • [7] Pharmacokinetics of ribavirin in combined interferon-alpha 2b and ribavirin therapy for chronic hepatitis C virus infection
    Tsubota, A
    Hirose, Y
    Izumi, N
    Kumada, H
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 55 (04) : 360 - 367
  • [8] Histiocytic cytophagic panniculitis which developed during interferon-alpha therapy
    Kuno, M
    Mimori, A
    Fujii, T
    Takeda, A
    Masuyama, J
    Yoshio, T
    Minota, S
    Kano, S
    INTERNAL MEDICINE, 1996, 35 (02) : 115 - 118
  • [9] IMMUNOLOCALIZATION OF INTERFERON-ALPHA IN HEPATITIS-C PATIENTS AND ITS CORRELATION WITH RESPONSE TO INTERFERON-ALPHA THERAPY
    GREENWAY, AL
    HERTZOG, PJ
    DEVENISH, RJ
    DUDLEY, FJ
    MCMULLEN, GL
    LINNANE, AW
    JOURNAL OF HEPATOLOGY, 1994, 21 (05) : 842 - 852
  • [10] Tongue hyperpigmentation resulting from peginterferon alfa and ribavirin combination therapy A case report
    de Moraes, Paulo Camargo
    Noce, Cesar Werneck
    Thomaz, Luis Alexandre
    Mautoni, Mario Claudio
    Pizzigatti Correa, Maria Elvira
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2009, 140 (11): : 1377 - 1379
12345